CASI Pharmaceuticals (CASIF) Minority Interest (2021 - 2022)
CASI Pharmaceuticals (CASIF) reported Minority Interest of $22.4 million for Q4 2022, down 4.69% on a YoY basis from $23.5 million in Q4 2021, and down 4.69% quarter-over-quarter from $23.5 million in Q4 2021.
CASI Pharmaceuticals (CASIF) Minority Interest (2021 - 2022) Analysis & Trends
CASI Pharmaceuticals has reported Minority Interest for 2 years, with the latest figure at $22.4 million in Q4 2022.
- For the quarter ending Q4 2022, Minority Interest fell 4.69% year-over-year to $22.4 million; the trailing twelve-month figure through Dec 2022 stood at $22.4 million (down 4.69% YoY), and the FY2022 full-year result was $22.4 million, down 4.69% from the prior year.
- Minority Interest for Q4 2022 stood at $22.4 million, down from $23.5 million in the prior quarter.
- The five-year high for Minority Interest was $23.5 million in Q4 2021, with the low at $22.4 million in Q4 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 860,679.92 Bn | 860,679.89 Bn | - |
| 2 | Belite Bio | 55,284.00 Bn | 55,284.00 Bn | - |
| 3 | Quantum Biopharma | 16,206.94 Bn | 16,206.93 Bn | - |
| 4 | Legend Biotech | 3,318.00 Bn | 3,317.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,543.84 Bn | 1,543.84 Bn | - |
| 6 | Evaxion A | 1,449.11 Bn | 1,449.09 Bn | - |
| 7 | Psyence Biomedical | 216.99 Bn | 216.98 Bn | - |
| 8 | Vertex Pharmaceuticals | 115.22 Bn | 107.97 Bn | 2.59 Bn |
| 9 | Abivax | 90.58 Bn | 90.58 Bn | - |
| 10 | CASI Pharmaceuticals | - | - | 3.69 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2022 | 22.36 Mn |
| Dec 31, 2021 | 23.46 Mn |